Search company, investor...

Predict your next investment

Corporation

Investments

1

About Hebei Viroad Biotechnology

Hebei Viroad Biotechnology is a China-based biotechnology company.

Headquarters Location

Shijiazhuang, Hebei,

China

Want to inform investors similar to Hebei Viroad Biotechnology about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Hebei Viroad Biotechnology Investments

1 Investments

Hebei Viroad Biotechnology has made 1 investments. Their latest investment was in GILUPI as part of their Corporate Minority on December 12, 2012.

CBI Logo

Hebei Viroad Biotechnology Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/1/2012

Corporate Minority

GILUPI

Yes

1

Date

12/1/2012

Round

Corporate Minority

Company

GILUPI

Amount

New?

Yes

Co-Investors

Sources

1

Hebei Viroad Biotechnology Acquisitions

1 Acquisition

Hebei Viroad Biotechnology acquired 1 company. Their latest acquisition was GILUPI on December 14, 2016.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/14/2016

Other

$99M

$4.8M

Acquired

2

Date

12/14/2016

Investment Stage

Other

Companies

Valuation

$99M

Total Funding

$4.8M

Note

Acquired

Sources

2

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.